Skip to main navigation

Main Nav

About Us
Scientific Platform
Our Pipeline
Career Opportunities
Investors & Media

Press Releases

IR Nav

Overview
Press Releases
Events
Presentations
Annual Reports
Corporate Governance
SEC Filings
Stock Information
Analyst Coverage
FAQs
Email Alerts
Investor Contact

Shareholder Tools

Press Releases

Year

Gritstone bio Announces Presentations on Neoantigen Prediction Capabilities and Cancer Vaccine Programs at the 2023 AACR Annual Meeting

March 15, 2023

Gritstone bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Updates

March 9, 2023

Gritstone bio to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update on March 9, 2023

March 2, 2023

Gritstone bio to Participate in 43rd Annual Cowen Healthcare Conference

February 27, 2023

Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 27, 2023

Gritstone bio and the National Cancer Institute (NCI) Establish a Clinical Trial Agreement to Evaluate a Neoantigen Cell Therapy-Vaccine Combination

February 14, 2023

Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 24, 2023

Gritstone bio to Participate in Upcoming Investor Conferences

January 18, 2023

Gritstone bio to Present at 41st Annual J.P. Morgan Healthcare Conference

December 15, 2022

Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

December 15, 2022

Pagination

First page
Previous page
…
Page 2
Page 3
Page 4
Page 5
Current page 6
Page 7
Page 8
Page 9
Page 10
…
Next page
Last page

© 2024 Gritstone Bio |

Footer Links

Privacy Policy
Terms of Use
Cookie Policy
Contact

socials

Top